FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 310:1500-1505 June 7, 1984 Number 23 Next

	Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited PubMed Citation

Abstract

We studied 26 children with inborn errors of urea synthesis who survived neonatal hyperammonemic coma. There was a 92 per cent one-year survival rate associated with nitrogen-restriction therapy and stimulation of alternative pathways of waste nitrogen excretion. Seventy-nine per cent of the children had one or more developmental disabilities at 12 to 74 months of age; the mean IQ was 43 +/- 6. There was a significant negative linear correlation between duration of Stage III or IV neonatal hyperammonemic coma and IQ at 12 months (r = -0.72, P less than 0.001) but not between the peak ammonium level (351 to 1800 microM) and IQ. There was also a significant correlation between CT abnormalities and duration of hyperammonemic coma (r = 0.85, P less than 0.01) and between CT abnormalities and concurrent IQ (r = -0.75, P less than 0.02). These results suggest that prolonged neonatal hyperammonemic coma is associated with brain damage and impairment of intellectual function. This outcome may be prevented by early diagnosis and therapy.

This article has been cited by other articles:

• Clay, A. S., Hainline, B. E. (2007). Hyperammonemia in the ICU. Chest 132: 1368-1378 [Abstract] [Full Text]  
• de Boo, H A, Harding, J E (2007). Protein metabolism in preterm infants with particular reference to intrauterine growth restriction. Arch. Dis. Child. Fetal Neonatal Ed. 92: F315-F319 [Abstract] [Full Text]  
• Enns, G. M., Berry, S. A., Berry, G. T., Rhead, W. J., Brusilow, S. W., Hamosh, A. (2007). Survival after Treatment with Phenylacetate and Benzoate for Urea-Cycle Disorders. NEJM 356: 2282-2292 [Abstract] [Full Text]  
• Niemi, A.-K., Enns, G. M. (2006). Pharmacology Review: Sodium Phenylacetate and Sodium Benzoate in the Treatment of Neonatal Hyperammonemia. NeoReviews 7: e486-e495 [Full Text]  
• Haller, M., Henzler-Le Boulanger, A., Sass, J. O., Brandis, M., Zimmerhackl, L. B. (2005). Successful extracorporeal treatment of a male with hyperammonaemic coma. Nephrol Dial Transplant 20: 453-455 [Full Text]  
• McBride, K. L., Miller, G., Carter, S., Karpen, S., Goss, J., Lee, B. (2004). Developmental Outcomes With Early Orthotopic Liver Transplantation for Infants With Neonatal-Onset Urea Cycle Defects and a Female Patient With Late-Onset Ornithine Transcarbamylase Deficiency. Pediatrics 114: e523-e526 [Abstract] [Full Text]  
• Scaglia, F., Brunetti-Pierri, N., Kleppe, S., Marini, J., Carter, S., Garlick, P., Jahoor, F., O'Brien, W., Lee, B. (2004). Clinical Consequences of Urea Cycle Enzyme Deficiencies and Potential Links to Arginine and Nitric Oxide Metabolism. J. Nutr. 134: 2775S-2782S [Abstract] [Full Text]  
• Rimbaux, S, Hommet, C, Perrier, D, Cottier, J P, Legras, A, Labarthe, F, Lemarcis, L, Autret, A, Maillot, F (2004). Adult onset ornithine transcarbamylase deficiency: an unusual cause of semantic disorders. J. Neurol. Neurosurg. Psychiatry 75: 1073-1075 [Abstract] [Full Text]  
• Endo, F., Matsuura, T., Yanagita, K., Matsuda, I. (2004). Clinical Manifestations of Inborn Errors of the Urea Cycle and Related Metabolic Disorders during Childhood. J. Nutr. 134: 1605S-1609S [Abstract] [Full Text]  
• Takanashi, J.-i., Barkovich, A. J., Cheng, S. F., Weisiger, K., Zlatunich, C. O., Mudge, C., Rosenthal, P., Tuchman, M., Packman, S. (2003). Brain MR Imaging in Neonatal Hyperammonemic Encephalopathy Resulting from Proximal Urea Cycle Disorders. Am. J. Neuroradiol. 24: 1184-1187 [Abstract] [Full Text]  
• Takanashi, J.-i., Barkovich, A. J., Cheng, S. F., Kostiner, D., Baker, J. C., Packman, S. (2003). Brain MR Imaging in Acute Hyperammonemic Encephalopathy Arising from Late-Onset Ornithine Transcarbamylase Deficiency. Am. J. Neuroradiol. 24: 390-393 [Abstract] [Full Text]  
• Braissant, O., Henry, H., Villard, A.-M., Zurich, M.-G., Loup, M., Eilers, B., Parlascino, G., Matter, E., Boulat, O., Honegger, P., Bachmann, C. (2002). Ammonium-Induced Impairment of Axonal Growth Is Prevented through Glial Creatine. J. Neurosci. 22: 9810-9820 [Abstract] [Full Text]  
• Nicolaides, P, Liebsch, D, Dale, N, Leonard, J, Surtees, R (2002). Neurological outcome of patients with ornithine carbamoyltransferase deficiency. Arch. Dis. Child. 86: 54-56 [Abstract] [Full Text]  
• Lemley, K. V., Hintz, S. R., Enns, G. M. (2000). Continuous Renal Replacement Therapy in the Initial Management of Neonatal Hyperammonemia Due to Urea Cycle Defects. NeoReviews 1: e173-179 [Full Text]  
• Brunquell, P., Tezcan, K., DiMario, F. J. JR (1999). Electroencephalographic Findings in Ornithine Transcarbamylase Deficiency. J Child Neurol 14: 533-536 [Abstract]  
• Lee, B., Dennis, J. A., Healy, P. J., Mull, B., Pastore, L., Yu, H., Aguilar-Cordova, E., O'Brien, W., Reeds, P., Beaudet, A. L. (1999). Hepatocyte gene therapy in a large animal: A neonatal bovine model of citrullinemia. Proc. Natl. Acad. Sci. USA 96: 3981-3986 [Abstract] [Full Text]  
• Maestri, N. E., Brusilow, S. W., Clissold, D. B., Bassett, S. S. (1996). Long-Term Treatment of Girls with Ornithine Transcarbamylase Deficiency. NEJM 335: 855-860 [Abstract] [Full Text]  
• Pridmore, C. L., Clarke, J. T.R., Blaser, S. (1995). Ornithine Transcarbamylase Deficiency in Females: An Often Overlooked Cause of Treatable Encephalopathy. J Child Neurol 10: 369-374 [Abstract]  
• Lee, B., Yu, H., Jahoor, F., O'Brien, W., Beaudet, A. L., Reeds, P. (2000). In vivo urea cycle flux distinguishes and correlates with phenotypic severity in disorders of the urea cycle. Proc. Natl. Acad. Sci. USA 97: 8021-8026 [Abstract] [Full Text]